Endo Int’l: New CEO “Has His Work Cut Out For Him”

The arrival of a new chief executive can be just what the doctor prescribed for beleaguered companies. But will the departure of Rajiv De Silva from the helm of Endo International ( ENDP ) help the troubled specialty drug maker overcome recent struggles ? Wall Street sure thinks so. The specialty drug maker’s stock price rose surged more than 17% in recent market action, to $23.74 followed today’s announcement